← Patent-cliff monitor Loss of exclusivity January 2039 latest FDA-listed patent expiry
Company JOURNEY MEDICAL CORP
Drug detail Brand name EMROSI Active ingredient MINOCYCLINE HYDROCHLORIDE Strength EQ 40MG BASE Dosage form CAPSULE, EXTENDED RELEASE Route ORAL Modality Small molecule FDA approval November 2024 Marketing status RX
Listed patents Patent Expires Type 11364212 January 2039 use U-4043 11191740 January 2039 use U-4043 10905664 January 2039 use U-4043 12594252 January 2039 use U-4043
Regulatory exclusivity Code Expires NP November 2027
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.